Daniel C. Javitt
#97,097
Most Influential Person Now
Daniel C. Javitt's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Daniel C. Javitt Influential?
(Suggest an Edit or Addition)Daniel C. Javitt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Recent advances in the phencyclidine model of schizophrenia. (1991) (2873)
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia (2008) (964)
- Multisensory auditory-visual interactions during early sensory processing in humans: a high-density electrical mapping study. (2002) (858)
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment (2012) (820)
- The NKI-Rockland Sample: A Model for Accelerating the Pace of Discovery Science in Psychiatry (2012) (623)
- Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. (1996) (610)
- Do you see what I am saying? Exploring visual enhancement of speech comprehension in noisy environments. (2006) (605)
- Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. (2000) (562)
- Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. (2007) (528)
- Glutamate as a therapeutic target in psychiatric disorders (2004) (503)
- Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. (1999) (475)
- When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. (2009) (473)
- Automated analysis of free speech predicts psychosis onset in high-risk youths (2015) (449)
- Auditory-somatosensory multisensory processing in auditory association cortex: an fMRI study. (2002) (410)
- Amplitude of low-frequency oscillations in schizophrenia: A resting state fMRI study (2010) (409)
- Somatosensory input to auditory association cortex in the macaque monkey. (2001) (400)
- Multisensory auditory-somatosensory interactions in early cortical processing revealed by high-density electrical mapping. (2000) (399)
- Grabbing your ear: rapid auditory-somatosensory multisensory interactions in low-level sensory cortices are not constrained by stimulus alignment. (2005) (396)
- The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. (2007) (390)
- The Spectrotemporal Filter Mechanism of Auditory Selective Attention (2013) (380)
- Multisensory visual-auditory object recognition in humans: a high-density electrical mapping study. (2004) (371)
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia? (2010) (369)
- D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia (2005) (348)
- Dysfunction of early-stage visual processing in schizophrenia. (2001) (347)
- Early-stage visual processing and cortical amplification deficits in schizophrenia. (2005) (347)
- Amelioration of negative symptoms in schizophrenia by glycine. (1994) (344)
- The neural circuitry of pre-attentive auditory change-detection: an fMRI study of pitch and duration mismatch negativity generators. (2005) (340)
- The Leading Sense: Supramodal Control of Neurophysiological Context by Attention (2009) (339)
- Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia. (2002) (330)
- The Spatiotemporal Dynamics of Illusory Contour Processing: Combined High-Density Electrical Mapping, Source Analysis, and Functional Magnetic Resonance Imaging (2002) (308)
- Neurophysiological biomarkers for drug development in schizophrenia (2008) (305)
- Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia. (1995) (300)
- A topography of executive functions and their interactions revealed by functional magnetic resonance imaging. (2004) (300)
- Attention-dependent suppression of distracter visual input can be cross-modally cued as indexed by anticipatory parieto-occipital alpha-band oscillations. (2001) (290)
- Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. (2015) (283)
- Glutamatergic theories of schizophrenia. (2010) (279)
- Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments. (2007) (276)
- Early-stage visual processing deficits in schizophrenia (2005) (276)
- Sensory processing in schizophrenia: neither simple nor intact. (2009) (272)
- Auditory dysfunction in schizophrenia: integrating clinical and basic features (2015) (270)
- MRI study of white matter diffusion anisotropy in schizophrenia (2003) (268)
- Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. (2012) (264)
- Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia (1996) (254)
- Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. (1987) (251)
- Activation Timecourse of Ventral Visual Stream Object-recognition Areas: High Density Electrical Mapping of Perceptual Closure Processes (2000) (249)
- Impairment of early cortical processing in schizophrenia: An event-related potential confirmation study (1993) (234)
- Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. (2000) (232)
- The initial field trials of DSM-5: new blooms and old thorns. (2013) (231)
- Prediction of psychosis across protocols and risk cohorts using automated language analysis (2018) (230)
- Right hemisphere control of visuospatial attention: line-bisection judgments evaluated with high-density electrical mapping and source analysis☆ (2003) (227)
- Associated deficits in mismatch negativity generation and tone matching in schizophrenia (2000) (225)
- Prefrontal‐subcortical dissociations underlying inhibitory control revealed by event‐related fMRI (2004) (223)
- Effects of clozapine on auditory event-related potentials in schizophrenia (1998) (217)
- Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval. (1998) (214)
- High dose D-serine in the treatment of schizophrenia (2010) (210)
- Sensory Contributions to Impaired Prosodic Processing in Schizophrenia (2005) (208)
- Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention (2018) (208)
- High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia (2004) (203)
- The Mismatch Negativity of Event‐Related Potentials as a Probe of Transient Auditory Memory: A Review (1995) (201)
- Adjunctive high-dose glycine in the treatment of schizophrenia. (2001) (198)
- Activation of Inhibition: Diminishing Impulsive Behavior by Direct Current Stimulation over the Inferior Frontal Gyrus (2011) (197)
- A human intracranial study of long-range oscillatory coherence across a frontal–occipital–hippocampal brain network during visual object processing (2008) (188)
- Early visual processing deficits in schizophrenia: impaired P1 generation revealed by high-density electrical mapping (2001) (188)
- Electrophysiological Indices of Automatic and Controlled Auditory Information Processing in First-Episode, Recent-Onset and Chronic Schizophrenia (2006) (185)
- Magnocellular Pathway Impairment in Schizophrenia: Evidence from Functional Magnetic Resonance Imaging (2008) (185)
- Multisensory convergence in auditory cortex, I. Cortical connections of the caudal superior temporal plane in macaque monkeys (2007) (183)
- Filling-in in schizophrenia: a high-density electrical mapping and source-analysis investigation of illusory contour processing. (2005) (183)
- Imaging glutamate in schizophrenia: review of findings and implications for drug discovery (2014) (182)
- Setting Boundaries: Brain Dynamics of Modal and Amodal Illusory Shape Completion in Humans (2004) (181)
- A Roadmap for the Development and Validation of Event-Related Potential Biomarkers in Schizophrenia Research (2011) (177)
- Impaired multisensory processing in schizophrenia: Deficits in the visual enhancement of speech comprehension under noisy environmental conditions (2007) (176)
- Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. (2002) (175)
- Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. (2007) (173)
- Intracortical Mechanisms of Mismatch Negativity Dysfunction in Schizophrenia (2000) (166)
- Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction (1999) (164)
- Demonstration of mismatch negativity in the monkey. (1992) (162)
- Visuo-spatial neural response interactions in early cortical processing during a simple reaction time task: a high-density electrical mapping study (2001) (162)
- Auditory sensory dysfunction in schizophrenia: imprecision or distractibility? (2000) (161)
- Impaired precision, but normal retention, of auditory sensory ("echoic") memory information in schizophrenia. (1997) (160)
- Visual Perceptual Learning in Human Object Recognition Areas: A Repetition Priming Study Using High-Density Electrical Mapping (2001) (157)
- A Randomized Clinical Trial of MK-0777 for the Treatment of Cognitive Impairments in People with Schizophrenia (2011) (154)
- Translating Glutamate: From Pathophysiology to Treatment (2011) (153)
- Functional anatomy and interaction of fast and slow visual pathways in macaque monkeys. (2007) (150)
- Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia (2005) (148)
- Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings (2014) (147)
- The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents. (2007) (143)
- Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives. (2006) (140)
- Getting the cue: sensory contributions to auditory emotion recognition impairments in schizophrenia. (2010) (139)
- “It's Not What You Say, But How You Say it”: A Reciprocal Temporo-frontal Network for Affective Prosody (2009) (139)
- Sensory contributions to impaired emotion processing in schizophrenia. (2009) (138)
- Glutamatergic transmission in schizophrenia: from basic research to clinical practice (2012) (137)
- Magnocellular contributions to impaired motion processing in schizophrenia (2006) (137)
- Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels. (1989) (136)
- Spatiotemporal dynamics of human object recognition processing: An integrated high-density electrical mapping and functional imaging study of “closure” processes (2006) (136)
- Amygdalofrontal functional disconnectivity and aggression in schizophrenia. (2010) (136)
- Impaired sensory processing as a basis for object-recognition deficits in schizophrenia. (2001) (133)
- Predicting Success: Patterns of Cortical Activation and Deactivation Prior to Response Inhibition (2004) (133)
- Task switching: a high-density electrical mapping study (2003) (132)
- Visual backward-masking deficits in schizophrenia: relationship to visual pathway function and symptomatology (2003) (132)
- Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia (2003) (131)
- The role of N-Methyl-D-Aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes (1998) (129)
- A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression. (2013) (127)
- Decreased interhemispheric coordination in schizophrenia: A resting state fMRI study (2012) (123)
- Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis (2004) (123)
- Cellular generators of the cortical auditory evoked potential initial component. (1992) (122)
- Objects Are Highlighted by Spatial Attention (2006) (119)
- D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial. (2015) (119)
- Effects of risperidone on auditory event-related potentials in schizophrenia. (1999) (119)
- Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: an integrated neuroimaging study. (2010) (118)
- Early sensory contributions to contextual encoding deficits in schizophrenia. (2011) (118)
- Inhibition of System A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action (2005) (117)
- Cortical thinning, functional connectivity, and mood-related impulsivity in schizophrenia: relationship to aggressive attitudes and behavior. (2014) (117)
- Boundary Completion Is Automatic and Dissociable from Shape Discrimination (2006) (116)
- Reading impairment and visual processing deficits in schizophrenia (2006) (112)
- Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type. (2005) (112)
- Auditory sensory ("echoic") memory dysfunction in schizophrenia. (1995) (112)
- Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia (2012) (111)
- Localization of ERP generators and identification of underlying neural processes. (1995) (111)
- DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis (2004) (110)
- Sensory deficits and distributed hierarchical dysfunction in schizophrenia. (2010) (109)
- Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia (2006) (109)
- Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective (2015) (106)
- Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. (2010) (106)
- Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification. (2009) (106)
- Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors (1999) (102)
- Twenty-five years of glutamate in schizophrenia: are we there yet? (2012) (101)
- Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia (2004) (101)
- Predictive Suppression of Cortical Excitability and Its Deficit in Schizophrenia (2013) (99)
- Glycine Transport Inhibitors and the Treatment of Schizophrenia (2008) (96)
- Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia. (1999) (95)
- Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-site Agonists (2004) (95)
- Auditory emotion recognition impairments in schizophrenia: relationship to acoustic features and cognition. (2012) (94)
- Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. (2002) (92)
- Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients (2006) (91)
- A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. (2012) (91)
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms (2018) (90)
- Reading deficits in schizophrenia and individuals at high clinical risk: relationship to sensory function, course of illness, and psychosocial outcome. (2014) (90)
- Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys (2003) (89)
- Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial (1996) (89)
- Neural mechanisms of mismatch negativity (MMN) dysfunction in schizophrenia (2016) (88)
- Jumping the gun: is effective preparation contingent upon anticipatory activation in task-relevant neural circuitry? (2006) (88)
- Global dynamics of selective attention and its lapses in primary auditory cortex (2016) (88)
- Timing of pure tone and noise-evoked responses in macaque auditory cortex (2005) (86)
- Dysfunction of early-stage visual processing in schizophrenia: harmonic analysis (2005) (86)
- Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia. (1998) (81)
- The Role of Spatial Attention in the Selection of Real and Illusory Objects (2007) (81)
- Seeing the world dimly: the impact of early visual deficits on visual experience in schizophrenia. (2009) (79)
- Theory of Mind (ToM) and counterfactuality deficits in schizophrenia: misperception or misinterpretation? (2006) (78)
- Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder. (2006) (77)
- Reversal of Phencyclidine-Induced Hyperactivity by Glycine and the Glycine Uptake Inhibitor Glycyldodecylamide (1997) (77)
- In support of Bleuler: Objective evidence for increased affective ambivalence in schizophrenia based upon evocative testing (2009) (77)
- Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP) (2000) (76)
- Consequences of magnocellular dysfunction on processing attended information in schizophrenia. (2012) (76)
- Differential Relationships of Mismatch Negativity and Visual P1 Deficits to Premorbid Characteristics and Functional Outcome in Schizophrenia (2012) (76)
- Changing plans: a high density electrical mapping study of cortical control. (2003) (75)
- Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial (2018) (74)
- Subchronic Continuous Phencyclidine Administration Potentiates Amphetamine-Induced Frontal Cortex Dopamine Release (2003) (74)
- Electrophysiological indices of information processing in methylphenidate responders (1997) (72)
- Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine. (2016) (71)
- Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia (2015) (70)
- The role of excitatory amino acids in neuropsychiatric illness. (1990) (69)
- Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuse (1997) (69)
- What's in a face? Effects of stimulus duration and inversion on face processing in schizophrenia (2008) (69)
- Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults. (2009) (68)
- Early Visual Processing Deficits in Dysbindin-Associated Schizophrenia (2008) (68)
- Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia (2018) (67)
- Reduction in tonal discriminations predicts receptive emotion processing deficits in schizophrenia and schizoaffective disorder. (2013) (66)
- Replacing DSM Categorical Analyses With Dimensional Analyses in Psychiatry Research: The Research Domain Criteria Initiative. (2015) (66)
- Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys (2001) (65)
- Glycine modulators in schizophrenia. (2002) (64)
- Understanding tDCS effects in schizophrenia: a systematic review of clinical data and an integrated computation modeling analysis (2014) (63)
- Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain. (1989) (63)
- Don't think of a white bear: An fMRI investigation of the effects of sequential instructional sets on cortical activity in a task‐switching paradigm (2004) (62)
- Neurophysiological and neurochemical animal models of schizophrenia: Focus on glutamate (2009) (62)
- Contributions of low and high spatial frequency processing to impaired object recognition circuitry in schizophrenia. (2013) (61)
- Continuous Phencyclidine Treatment Induces Schizophrenia-Like Hyperreactivity of Striatal Dopamine Release (2001) (61)
- Non-competitive regulation of phencyclidine/σ-receptors by the N-methyl-d-aspartate receptor antagonist d-(−)-2-amino-5-phosphonovaleric acid (1987) (61)
- Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia. (2006) (61)
- Cognitive event-related potentials in human and non-human primates: implications for the PCP/NMDA model of schizophrenia. (1995) (61)
- Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia (2013) (59)
- Loneliness in schizophrenia and its possible correlates. An exploratory study (2016) (59)
- Distinct Neurophysiological Mechanisms Mediate Mixing Costs and Switch Costs (2009) (59)
- MISMATCH NEGATIVITY IN HYPERACTIVE CHILDREN:EFFECTS OF METHYLPHENIDATE (1993) (58)
- Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies (2013) (58)
- Neurophysiological models for new treatment development in schizophrenia: early sensory approaches (2015) (58)
- Functional connectivity fMRI in mouse brain at 7T using isoflurane (2013) (56)
- GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum (2009) (56)
- GABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications. (2009) (56)
- Anticipated, on-line and remembered positive experience in schizophrenia (2010) (56)
- Glycine transport inhibitors in the treatment of schizophrenia. (2012) (55)
- Expectancy-related modulations of neural oscillations in continuous performance tasks (2012) (54)
- Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings. (2015) (53)
- Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia (2005) (52)
- Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia (2018) (52)
- The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review. (2019) (51)
- Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia. (1996) (51)
- Phencyclidine-Induced Dysregulation of Dopamine Response to Amphetamine in Prefrontal Cortex and Striatum (2001) (48)
- Treatment of negative and cognitive symptoms (1999) (48)
- The 5% difference: early sensory processing predicts sarcasm perception in schizophrenia and schizo-affective disorder (2013) (48)
- Nitric oxide synthase interneurons in the monkey cerebral cortex are subsets of the somatostatin, neuropeptide Y, and calbindin cells (2000) (48)
- Visual white matter integrity in schizophrenia. (2006) (47)
- Modulation of Striatal Dopamine Release by Glycine Transport Inhibitors (2005) (46)
- Impaired categorical perception of synthetic speech sounds in schizophrenia (1999) (45)
- Visual form perception: A comparison of individuals at high risk for psychosis, recent onset schizophrenia and chronic schizophrenia (2007) (44)
- Impaired early visual response modulations to spatial information in chronic schizophrenia (2011) (44)
- Efference Copy Failure during Smooth Pursuit Eye Movements in Schizophrenia (2013) (44)
- Comparison of psychophysical, electrophysiological, and fMRI assessment of visual contrast responses in patients with schizophrenia (2013) (43)
- Changing plans: neural correlates of executive control in monkey and human frontal cortex (2006) (43)
- Cognitive control processes during an anticipated switch of task (2003) (43)
- Pupillometer-Based Neurofeedback Cognitive Training to Improve Processing Speed and Social Functioning in Individuals at Clinical High Risk for Psychosis (2017) (43)
- A New Dimension of Sensory Dysfunction: Stereopsis Deficits in Schizophrenia (2006) (43)
- Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis (2015) (43)
- Hemispheric asymmetry and callosal integration of visuospatial attention in schizophrenia: A tachistoscopic line bisection study (2008) (39)
- Perceptual organization by proximity and similarity in schizophrenia (2007) (38)
- Differential Patterns of Visual Sensory Alteration Underlying Face Emotion Recognition Impairment and Motion Perception Deficits in Schizophrenia and Autism Spectrum Disorder (2019) (38)
- Glutamate receptors as therapeutic targets (2004) (38)
- Loss aversion in schizophrenia (2008) (38)
- Normal time course of auditory recognition in schizophrenia, despite impaired precision of the auditory sensory ("echoic") memory code. (1999) (38)
- Management of negative symptoms of schizophrenia (2001) (38)
- Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia (2018) (37)
- Behavioral effects of chronic phencyclidine in monkeys. (1999) (37)
- D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease. (2012) (37)
- High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients (2007) (36)
- The Thalamocortical Circuit of Auditory Mismatch Negativity (2019) (36)
- Impaired magnocellular/dorsal stream activation predicts impaired reading ability in schizophrenia☆ (2012) (35)
- Significant improvement in treatment resistant auditory verbal hallucinations after 5 days of double-blind, randomized, sham controlled, fronto-temporal, transcranial direct current stimulation (tDCS): A replication/extension study (2019) (35)
- Magnocellular training improves visual word recognition (2012) (34)
- A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology (2020) (34)
- A novel alanine-insensitive d-serine transporter in rat brain synaptosomal membranes (2002) (33)
- Chronic high-dose glycine nutrition: effects on rat brain cell morphology (2001) (33)
- Encoding vs. retention: Differential effects of cue manipulation on working memory performance in schizophrenia (2007) (33)
- Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: implications for pathophysiology of executive dysfunction in schizophrenia. (2010) (33)
- Abnormal task modulation of oscillatory neural activity in schizophrenia (2013) (32)
- The role of response requirements in task switching: dissolving the residue (2004) (32)
- N-methyl-d-aspartate enhancement of phasic responses in primate neocortex (1997) (32)
- A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia (2018) (32)
- Premature disinhibition of P3 generation in schizophrenia (1996) (31)
- Resting state functional connectivity predictors of treatment response to electroconvulsive therapy in depression (2019) (31)
- Fractal Dimension Analysis of Subcortical Gray Matter Structures in Schizophrenia (2016) (30)
- Neurophysiological Effects of Bitopertin in Schizophrenia (2017) (30)
- Altered volume and hemispheric asymmetry of the superficial cortical layers in the schizophrenia planum temporale (2009) (29)
- Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine (2007) (29)
- Differential profiles in auditory social cognition deficits between adults with autism and schizophrenia spectrum disorders: A preliminary analysis. (2016) (29)
- A pilot double-blind comparison of d-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia (2013) (29)
- Inpatients with schizophrenia report impaired situational motivation but intact global and social motivation (2013) (29)
- Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: Implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function (2008) (29)
- Neural oscillatory deficits in schizophrenia predict behavioral and neurocognitive impairments (2015) (28)
- Physiological release of striatal acetylcholine (in vivo): effect of somatostatin on dopaminergic–cholinergic interaction (2003) (28)
- Impact of baseline early auditory processing on response to cognitive remediation for schizophrenia (2019) (27)
- Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene (2019) (27)
- Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients (2020) (27)
- Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors (2018) (27)
- Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications. (2018) (27)
- Spatial localization deficits and auditory cortical dysfunction in schizophrenia (2010) (27)
- Mismatch negativity (MMN) to spatial deviants and behavioral spatial discrimination ability in the etiology of auditory verbal hallucinations and thought disorder in schizophrenia (2018) (27)
- Modulating NMDA Receptor Function with d-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model (2016) (27)
- Preattentively grouped tones do not elicit MMN with respect to each other. (2006) (26)
- Inhibition of striatal dopamine release by glycine and glycyldodecylamide (2000) (26)
- Sensory and cross-network contributions to response inhibition in patients with schizophrenia (2018) (25)
- Glycine site agonists of the N‐methyl‐d‐aspartate receptor and Parkinson's disease: A hypothesis (2013) (25)
- Decoding schizophrenia. (2004) (24)
- Hemispheric comparisons of neuron density in the planum temporale of schizophrenia and nonpsychiatric brains (2011) (23)
- Amusia and protolanguage impairments in schizophrenia (2014) (23)
- 2.5 Redox Dysregulation in Schizophrenia: Genetic Susceptibility and Pathophysiological Mechanisms (2009) (23)
- A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms (2019) (23)
- Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation. (1990) (23)
- Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder (2021) (23)
- Behavioral validation of avolition in schizophrenia (2012) (23)
- Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia (2019) (23)
- Inflammatory biomarkers in psychosis and clinical high risk populations (2019) (23)
- GABAB Receptors, Schizophrenia and Sleep Dysfunction (2009) (23)
- Schizophrenia, culture and neuropsychology: sensory deficits, language impairments and social functioning in Chinese-speaking schizophrenia patients (2011) (22)
- Targeting glutamate to treat schizophrenia: lessons from recent clinical studies (2016) (21)
- Mismatch negativity: A simple and useful biomarker of N-methyl-d-aspartate receptor (NMDAR)-type glutamate dysfunction in schizophrenia (2018) (21)
- Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers (2020) (21)
- Safety, tolerability and pharmacokinetics of open label sarcosine added on to anti-psychotic treatment in schizophrenia - preliminary study. (2015) (20)
- Clinical and Electrophysiological Effects of D-Serine in a Schizophrenia Patient Positive for Anti-N-Methyl-D-Aspartate Receptor Antibodies (2015) (20)
- Parcel-guided rTMS for depression (2020) (20)
- Hierarchical deficits in auditory information processing in schizophrenia (2019) (20)
- Handbook of neurochemistry and molecular neurobiology, schizophrenia (2009) (20)
- High dose glycine nutrition affects glial cell morphology in rat hippocampus and cerebellum. (1999) (17)
- Auditory tasks for assessment of sensory function and affective prosody in schizophrenia. (2014) (17)
- ERP evidence of hemispheric independence in visual word recognition (2011) (17)
- The importance of a good night's sleep: An open-label trial of the sodium salt of γ-hydroxybutyric acid in insomnia associated with schizophrenia (2010) (16)
- It's all in the cards: effect of stimulus manipulation on Wisconsin Card Sorting Test performance in schizophrenia (2009) (16)
- Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study (2019) (16)
- Developmental trajectory of mismatch negativity and visual event-related potentials in healthy controls: Implications for neurodevelopmental vs. neurodegenerative models of schizophrenia (2018) (16)
- Conflict of interest-- an issue for every psychiatrist. (2009) (15)
- Current and Emergent Treatments for Symptoms and Neurocognitive Impairment in Schizophrenia (2014) (15)
- Implicit emotion perception in schizophrenia. (2015) (15)
- Effect of frequency separation and stimulus rate on the mismatch negativity: an examination of the issue of refractoriness in humans (2000) (15)
- Complementary fMRI and EEG evidence for more efficient neural processing of rhythmic vs. unpredictably timed sounds (2015) (15)
- Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia (2012) (14)
- Preliminary Evidence of Pre-Attentive Distinctions of Frequency-Modulated Tones that Convey Affect (2011) (14)
- A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia. (2009) (14)
- Pharmacological Augmentation of NMDA Receptor Function for Treatment of Schizophrenia a (1995) (14)
- Auditory distraction and thought disorder in chronic schizophrenic inpatients: Evidence for separate contributions by incapacity and poor allocation and a subsyndrome related to the allocation deficit (2001) (14)
- Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: a clinical overview. (2014) (13)
- A century of sensory processing dysfunction in schizophrenia (2019) (13)
- Glycine and d-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia (2004) (13)
- Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque (2001) (13)
- Hemispheric asymmetry of primary auditory cortex and Heschl's gyrus in schizophrenia and nonpsychiatric brains (2013) (13)
- Phenomenology, aetiology and treatment of schizophrenia. (2008) (13)
- Immediate affective motivation is not impaired in schizophrenia (2014) (13)
- Biotypes in Psychosis: Has the RDoC Era Arrived? (2016) (12)
- Polyamine effects uponN-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists (1991) (12)
- Neural and functional correlates of impaired reading ability in schizophrenia (2019) (11)
- Glutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia (2009) (11)
- Deficits and compensation: Attentional control cortical networks in schizophrenia (2020) (11)
- Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia (2021) (10)
- Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex. (1994) (10)
- What you see is what you get: visual scanning failures of naturalistic social scenes in schizophrenia (2020) (10)
- Mismatch Negativity to Tonal Contours Suggests Preattentive Perception of Prosodic Content (2009) (10)
- Reply: A few remarks on assessing magnocellular sensitivity in patients with schizophrenia (2007) (9)
- Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout mice (2020) (9)
- Phencyclidine receptor binding as a probe of NMDA receptor functioning: implications for drug abuse research. (1993) (8)
- A naturalistic outcome study of risperidone treatment among hospital patients. (1996) (8)
- Neurophysiological Approaches to Analyzing Brain Dysfunction in Schizophrenia (1993) (8)
- Glutamate receptors and schizophrenia: opportunities and caveats. (1996) (8)
- Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies. (2013) (8)
- EFFECTS OF INTRANASAL AL-108 (DAVUNETIDE) ON NEUROCOGNITION AND FUNCTIONAL OUTCOME IN SCHIZOPHERENIA (2010) (8)
- Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning (2020) (7)
- Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research. (1989) (7)
- Peeling the onion: NMDA dysfunction as a unifying model in schizophrenia (2003) (7)
- Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058 (2021) (7)
- Comparison of cortical network effects of high-definition and conventional tDCS during visuomotor processing (2020) (7)
- A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients. (2002) (7)
- Auditory Sensory Dysfunction in Schizophrenia (2016) (7)
- Applying Transcranial Magnetic Stimulation (TMS) Over the Dorsal Visual Pathway Induces Schizophrenia-like Disruption of Perceptual Closure (2016) (7)
- Meeting overview: Sensory perception and schizophrenia, Lausanne, Switzerland June 31–July 1, 2014 (2015) (6)
- The Phencyclidine/N-Methyl-D-Aspartate (PCP/ NMDA) Model of Schizophrenia: Theoretical and Clinical Implications (1993) (6)
- Intracortical mechanisms underlying mismatch negativity (MMN) generation in monkeys: Implications for working memory and the PCP/NMDA model of schizophrenia (1995) (6)
- Sensitive and simple gas chromatographic-mass spectrometric determination for amphetamine in microdialysate and ultrafiltrate samples. (2004) (6)
- Early perceptual loss in depression (2007) (6)
- Failure to engage the temporoparietal junction/posterior superior temporal sulcus predicts impaired naturalistic social cognition in schizophrenia. (2021) (6)
- Are basic auditory processes involved in source-monitoring deficits in patients with schizophrenia? (2019) (6)
- Glutamate and schizophrenia (2011) (5)
- What can the study of first impressions tell us about attitudinal ambivalence and paranoia in schizophrenia? (2016) (5)
- Impaired Fixation-Related Theta Modulation Predicts Reduced Visual Span and Guided Search Deficits in Schizophrenia. (2020) (5)
- Mismatch negativity (MMN) in first episodic and chronic schizophrenic subjects (1995) (5)
- Mismatch negativity (MMN) as an index of impaired auditory sensory memory in schizophrenia (1995) (5)
- Bitopertin in schizophrenia: glass half full? (2016) (5)
- Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: exploring the treatment landscape. (2014) (5)
- Neurophysiological, Oculomotor, and Computational Modeling of Impaired Reading Ability in Schizophrenia. (2020) (5)
- Computational modeling of excitatory/inhibitory balance impairments in schizophrenia (2020) (5)
- MK-0777 FOR THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PEOPLE WITH SCHIZOPHRENIA (2010) (5)
- The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease (2022) (5)
- Cognitive Deficits and Poor Functional Outcomes in Schizophrenia: Clinical and Neurobiological Progress (2014) (4)
- Cognitive Impairment Associated with Schizophrenia: Toward Novel Therapeutics. (2022) (4)
- Glutamate involvement in schizophrenia : Focus on N-methyl-D-aspartate receptors (2006) (4)
- Dysfunctional encoding of auditory information in schizophrenia (1995) (4)
- Glutamate and Schizophrenia: From Theory to Treatment Implications (2014) (4)
- Clinical Efficacy and Target Engagement of Glutamatergic Drugs: Placebo-Controlled RCTs of Pomaglumetad and TS-134 for Reversal of Ketamine-Induced Psychotic Symptoms and PharmacoBOLD in Healthy Volunteers (2020) (4)
- Glutamate: New Hope for Schizophrenia Treatment: Research on Glutamatergic Dyfunction May Lead to Therapies Targeting Negative and Cognitive Symptoms (2011) (4)
- Disease-Specific Contribution of Pulvinar Dysfunction to Impaired Emotion Recognition in Schizophrenia (2021) (4)
- Excitatory Amino Acids in Schizophrenia: Both What You Have, and What You Do With Them (2018) (4)
- NMDA receptor augmentation therapy in schizophrenia (1995) (3)
- Lateral cortical interactions in schizophrenia: A visual evoked potential study (2003) (3)
- Serum levels of fluphenazine in schizophrenic outpatients maintained on two reduced doses of fluphenazine decanoate (1994) (3)
- P.2.041 High dose glycine added to olanzapine and risperidone for the treatment of schizophrenia (2003) (3)
- Has an important test been overlooked? Closure flexibility in schizophrenia (2010) (3)
- Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats (2019) (3)
- 526. Mechanisms of auditory working memory dysfunction in schizophrenia (1996) (3)
- Diet, Microbiome, and Neuropsychiatric Disorders (2018) (3)
- Distress intolerance, kynurenic acid, and schizophrenia. (2014) (3)
- Psychophysiology of schizophrenia (1997) (3)
- 417. Auditory event-related potentials (ERP) in first episode and chronic schizophrenia (1998) (3)
- The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures (2019) (2)
- Mismatch negativity, neuropsychological deficits and psychopathology in chronic schizophrenia (1995) (2)
- 567. NMDA-mediated neurophysiologic deficits in schizophrenia (2000) (2)
- Relationships between Diffusion Tensor Imaging and Resting State Functional Connectivity in Patients with Schizophrenia and Healthy Controls: A Preliminary Study (2021) (2)
- Deficits in mismatch negativity in schizophrenia: Predictor of outcome or result of illness progression? (2003) (2)
- Multimodal Computational Modeling of Visual Object Recognition Deficits but Intact Repetition Priming in Schizophrenia (2020) (2)
- Are glycine sites saturated in vivo? (2000) (2)
- Are Schizophrenia Patients Amusical? : The Role of Pitch and Rhythm in Auditory Emotion Recognition Impairments in Schizophrenia (2013) (2)
- Glycine therapy of schizophrenia (1996) (2)
- Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy. (1997) (2)
- Cognitive remediation and sensory processing deficits in schizophrenia (2003) (2)
- Seeing the World as it is: Mimicking Veridical Motion Perception in Schizophrenia Using Non-invasive Brain Stimulation in Healthy Participants (2018) (2)
- The possible role of dopamine autoreceptors in neuroleptic atypicality. (1988) (2)
- 26.4 LANGUAGE DISTURBANCE AS A PREDICTOR OF PSYCHOSIS ONSET IN YOUTH AT ENHANCED CLINICAL RISK (2018) (1)
- Early auditory processing dysfunction in schizophrenia: Mechanisms and implications (2023) (1)
- 227. ERP and behavioral indices of working memory dysfunction in schizophrenia (1996) (1)
- Primary visual dysfunction in schizophrenia: Relationship to white matter integrity inferred from diffusion tensor imaging (2003) (1)
- Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. (2022) (1)
- Smooth pursuit eye movements and motion prediction in patients with schizophrenia and untrained healthy controls (2012) (1)
- Cortical Modulation using Transcranial Direct Current Stimulation. (2014) (1)
- Translating Glutamate : From Pathophysiology to Treatment Citation Javitt (2012) (1)
- Cognitive Impairment in Schizophrenia: Neurobiological determinants of cognition (2013) (1)
- Modulation of phencyclidine receptors by excitatory amino acid receptor ligands. (1988) (1)
- Abnormal white matter integrity in schizophrenia and schizoaffective disorder revealed by diffusion tensor imaging (2003) (1)
- Event-related repetitive TMS to right posterior STS (but not OFA) in healthy volunteers (HV) briefly recapitulates face emotion recognition (FER) deficits of schizophrenia (2017) (1)
- S250. Associations Between Contrast Processes and Resting-State Functional Connectivity in Patients With Schizophrenia and Healthy Controls (2018) (1)
- Failure to engage the TPJ-pSTS during naturalistic scene processing in schizophrenia (2019) (1)
- Glycine and D-Cycloserine adjuvant pharmacotherapy for treatment-resistant schizophrenia (1998) (1)
- Impaired cognitive processing within 1° auditory cortex in schizophrenia (1994) (1)
- The N-methyl-D-aspartate receptor and schizophrenia. (1996) (1)
- A Mediation Reanalysis of Pathways From Frontal Dysfunction to Aggression: The Role of Emotional Impulsivity (2020) (1)
- Perceptual Closure Processes During Object Recognition: An Integrative Investigation in Humans (2005) (1)
- Auditory cortical generators of the mismatch-negativity in the cat and monkey — a comparative study (1997) (1)
- D-SERINE VS. PLACEBO IN THE TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENT OF SCHIZOPHRENIA (2008) (1)
- Dr. Butler and Colleagues Reply (2002) (1)
- P.1.g.006 TMS over the dorsal visual pathway generates schizophrenia-like visual-deficit in healthy controls (2009) (0)
- Differential coupling of the dorsolateral prefrontal cortex with default network and visual cortex in patients recovered from depression after convulsive therapy (2017) (0)
- Reading disability goes beyond consent forms. (2007) (0)
- arly Visual Processing Deficits in ysbindin-Associated Schizophrenia (0)
- Avolition in Schizophrenia Time Sampling Observational Measure (2015) (0)
- Mismatch negativity during treatment with clozapine (1995) (0)
- Review for "Impaired Interaural Correlation Processing in People with Schizophrenia" (2021) (0)
- 11. New directions in cortical electrophysiology: from basic neuroscience to clinical research (2000) (0)
- Evidencein Human Auditory Cortex: MEG Concurrent Encoding of Frequency and Amplitude (2015) (0)
- Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007 (2008) (0)
- Modulation of phencyclidine receptors by n methyl d aspartate receptor ligands (1987) (0)
- Sensory Processing Deficits Across Modalities in Schizophrenia (2006) (0)
- NEUROPHYSIOLOGY, BASIC AND CLINICAL: Phencyclidine (PCP)-induced de®cits of prepulse inhibition in monkeys (0)
- Seeing the world as it is: veridical motion perception in schizophrenia and effects of non-invasive transcranial electric stimulation (2016) (0)
- Feasibility and clinical utility of using the tone matching test for assessment of early auditory processing in schizophrenia (2023) (0)
- Faculty Opinions recommendation of Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). (2012) (0)
- S0033291720001646jra 2923..2932 (2021) (0)
- 39.2 MULTIMODAL INVESTIGATION OF CONVERGENT AND DIVERGENT PATTERNS OF ATYPICAL VISUAL PROCESSING UNDERLYING FACE EMOTION RECOGNITION AND MOTION PERCEPTION IN SCHIZOPHRENIA AND AUTISM (2019) (0)
- 104. Neural Basis of Reading Dysfunction in Schizophrenia (2018) (0)
- 680 Auditory event-related potentials (ERP) in first episode and chronic schizophrenia (1997) (0)
- Visual working-memory dysfunction and P3 in schizophrenia (1995) (0)
- A NaturalisticOutcome Studyof Risperidone TreatmentAmong StateHospitalPatients (1996) (0)
- Faculty Opinions recommendation of Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia. (2012) (0)
- Multi-state model of PCP/NMDA receptor functioning: implications for schizophrenia research (1989) (0)
- Applying Transcranial Magnetic Stimulation (TMS) Over the Dorsal Visual Pathway Induces Schizophrenia-like Disruption of Perceptual Closure (2016) (0)
- Impaired auditory sensory (“Echoic”) memory in schizophrenia (1994) (0)
- 428. Neurophysiological Mechanisms of Cortical Learning Plasticity Impairments in Schizophrenia and Modulation by the N-Methyl-D-Aspartate Type Glutamate Receptor Agonist D-Serine (2017) (0)
- Modulating Effects of Transcranial Direct Current Stimulation on Event Related Potentials in a Motor Sequence Task (2014) (0)
- S275. Failures of Oscillatory Entrainment in Individuals at Clinical High Risk for Schizophrenia (2018) (0)
- Faculty Opinions recommendation of Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. (2012) (0)
- Faculty Opinions recommendation of A meta-analysis of the effectiveness of psychological interventions for adults with skin conditions. (2012) (0)
- Targeting glutamate to treat schizophrenia: lessons from recent clinical studies (2016) (0)
- MMN as an index of premorbid function in schizophrenia (2009) (0)
- 681 Event-related potentials (ERP) during a visual working memory task in first episode and chronic schizophrenia (1997) (0)
- AX-CPT performance in schizophrenics varies with cue complexity (2003) (0)
- Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists (2018) (0)
- 306. Inflammatory Biomarkers in Psychosis (2017) (0)
- Modulating NMDA Receptor Function with d-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model (2016) (0)
- Speaker 4: Daniel Javitt, USA (2016) (0)
- 519.: The effects of clozapine treatment on auditory event-related potentials (aERP) (1996) (0)
- The Middle Temporal (MT+) area mediates global motion processing: evidence from patients with schizophrenia and non-invasive brain stimulation (2014) (0)
- Placebo-Controlled Trial of Lamotrigine Added to Conventional and Atypical Antipsychotics in (2004) (0)
- S21. EVENT-RELATED REPETITIVE TMS TO RIGHT POSTERIOR STS (BUT NOT OCCIPITAL FACE AREA) IN HEALTHY VOLUNTEERS (HV) BRIEFLY RECAPITULATES FACE EMOTION RECOGNITION (FER) DEFICITS OF SCHIZOPHRENIA (SZ) (2018) (0)
- "Glutamate-based treatment for schizophrenia: where do we go from here? (2014) (0)
- The road not taken: disconnection of a human-unique cortical pathway underlying naturalistic social perception in schizophrenia (2022) (0)
- Seeing the World as it is: Mimicking Veridical Motion Perception in Schizophrenia Using Non-invasive Brain Stimulation in Healthy Participants (2018) (0)
- ELECTROPHYSIOLOGICAL ACTIVITY RELATED TO MOTOR PREPARATION AND EXECUTIVE CONTROL IN THE AX-CPT TASK (2008) (0)
- 393. The effects of distractors on auditory sensory memory deficits in schizophrenia (1998) (0)
- F189. Deficits and Compensation in Attentional Networks in Schizophrenia (2019) (0)
- P.1.g.006 Emotion recognition vs. non-affective visual processing deficits in schizophrenia (2007) (0)
- 263. Abnormal categorical perception of simple speech sounds in schizophrenia (1996) (0)
- Computerized neurocognitive assessment: Clinical trials and FMRI applications (2003) (0)
- D-cycloserine (DCS) is Not Susceptible to Self-administration, unlike S-ketamine Using an Intravenous Self-administration Model in Naive and Ketamine-habituated Sprague-Dawley Rats (2022) (0)
- Transcranial Direct Current Stimulation Effects on Time/Frequency Relationships in Patients with Schizophrenia (2014) (0)
- Dr. Zukin and Dr. Javitt Reply (2006) (0)
- Translational Mechanistic Biomarkers for the 21st Century. (2021) (0)
- 677 Encoding vs trace decay: Specifying the mechanism underlying auditory working memory dysfunction in schizophrenia (1997) (0)
- 22 Transcranial Direct Current Stimulation Modulates Cortical Networks (2017) (0)
- S.08.04 Amino acid transporters as therapeutic targets in schizophrenia (2004) (0)
- PERCEPTUAL ORGANIZATION OF SIMILARITY AND PROXIMITY IS IMPAIRED IN SCHIZOPHRENIA (2008) (0)
- Faculty Opinions recommendation of Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba. (2012) (0)
- Premature disinhibition of visual P3 in schizophrenia (1994) (0)
- Pursuit eye movements and motion prediction in patients with schizophrenia (2012) (0)
- CVN058, a 5-HT3 Receptor Antagonist, Shows Acute, Dose Dependent Improvement of Mismatch Negativity in a Double-Blind, Placebo-Controlled, Single Dose Cross-Over Study in Schizophrenia and Schizoaffective Disorder (2021) (0)
- 39.1 BASELINE EARLY AUDITORY PROCESSING AS A TAILORING VARIABLE TO PERSONALIZE COGNITIVE REMEDIATION FOR SCHIZOPHRENIA (2019) (0)
- F1000Prime recommendation of A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence. (2012) (0)
- T35. SPEED OF FACE PROCESSING PREDICTS PSYCHOSIS IN AT-RISK YOUTHS (2019) (0)
- Poster #196 HIGH DOSE D-SERINE IN THE TREATMENT OF SCHIZOPHRENIA (2012) (0)
- Neuropathological correlates of auditory event-related potentials in recent-onset schizophrenia (1998) (0)
- Schizophrenia Decoding (2003) (0)
- Abnormal scanpaths in visual search correlate with contrast sensitivity deficits in schizophrenia (2006) (0)
- Deficits of visual organization in patients with schizophrenia (2003) (0)
- Corrigendum to “Comparison of psychophysical, electrophysiological, and fMRI assessment of visual contrast responses in patients with schizophrenia” [Neuroimage 67C (2013) 153–162] (2013) (0)
- PM370. Mismatch negativity and theta band oscillation in schizophrenia and rodent NMDAR models (2016) (0)
- NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: A randomized prospective phase 2 trial (2022) (0)
- Comprar Handbook of Neurochemistry and Molecular Neurobiology · Schizophrenia | Javitt, Daniel | 9780387303659 | Springer (2009) (0)
- 25.4 PROMOTING MYELIN REPAIR RESCUES MICE FROM SCHIZOPHRENIA-LIKE BEHAVIOR INDUCED BY SOCIAL ISOLATION (2018) (0)
- F181. A Randomized, Single-Blind, Parallel-Group Study to Evaluate the Effects of TS-134 on Ketamine- Induced Bold Signals in Resting fMRI in Healthy Adult Subjects (2019) (0)
- Faculty Opinions recommendation of Effective group training for patients with unexplained physical symptoms: a randomized controlled trial with a non-randomized one-year follow-up. (2012) (0)
- Retrospective Analysis of the Effect of Risperidone on Clinical Outcome (1997) (0)
- December 15, 2003 (2007) (0)
- 541. Deficits in and Compensation for Engagement of Social Cognition Areas in Schizophrenia during Naturalistic Viewing (2017) (0)
- Thank You to Reviewers (2016) (0)
- Abnormalities in visual cognition and associated impaired interactions between visual and attentional networks in schizophrenia and brief psychotic disorder (2022) (0)
- Computational mapping of brain networks (2016) (0)
- Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers (2023) (0)
- T218. Reduced Amplitude of Fixation-Related Potentials Predicts Impaired Serial Search Performance in Schizophrenia (2018) (0)
- Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning impairments in schizophrenia (2023) (0)
- EXECUTIVE CONTROL IN SCHIZOPHRENIA: SCHIZOPHRENIA PATIENTS SHOW TASK SWITCHING DEFICITS CONSISTENT WITH NMDA DYSFUNCTION, BUT NOT GLOBAL EXECUTIVE DEFICITS: IMPLICATIONS FOR PATHOPATHOLOGY (2008) (0)
- 416. Neuropathological correlates of auditory event-related potentials in recent-onset schizophrenia (1998) (0)
- Mini Quiz: Glutamate and Schizophrenia (2015) (0)
- Resting state functional connectivity predictors of treatment response to electroconvulsive therapy in depression (2019) (0)
- CPO 1 : Bipolar Disorders (2016) (0)
- Visual pathway deficits in schizophrenia: Varying luminance and spatial frequency in a contrast sensitivity task (2003) (0)
- The effect of clozapine treatment on mismatch negativity (1996) (0)
- Assessing resting state functional connectivity in people with schizophrenia and healthy controls (2011) (0)
- Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment (2023) (0)
- Differential patterns of functional dysconnectivity underlying impairments in mismatch negativity generation and voice emotion recognition in schizophrenia: a resting state fMRI analysis (2012) (0)
- Successful Targeted Treatment of a Medically Actionable Mutation in Psychotic Disorders (2015) (0)
- The taxonomy of affective dysprosodia in schizophrenia and its relation to acoustic cue perception: A preliminary investigation (2007) (0)
- [The phencyclidine-N-methyl-D-aspartate theory of schizophrenia: clinical applications]. (1994) (0)
- Mechanisms and Therapeutic Implications of Neuroleptic Atypicality (1989) (0)
- The Neural Circuitry of Delta Entrainment Deficits in Schizophrenia and its Implications (2020) (0)
- Improving Motor Function in Schizophrenia with Transcranial Direct Current Stimulation (2017) (0)
- GLUTAMATE IS SENSATIONAL. THINK ABOUT IT! (2008) (0)
- Comparison of high-definition and conventional tDCS on visuomotor sequence learning (2019) (0)
- A Voxelwise Analysis of the Relationship between White Matter Integrity and Impulsivity in Men with Schizophrenia (2004) (0)
- Cerebral GABA decrease in patients with schizophrenia measured by 1 H MR chemical shift imaging of GABA (2005) (0)
- Dosing regimen, the dispensing package of medication and uses thereof for the treatment of major depressive disorder (2012) (0)
- Advantages to schizophrenia? (2002) (0)
- Glutamate in the pathophysiology of schizophrenia (2020) (0)
- The road not taken: disconnection of a human-unique cortical pathway in schizophrenia and its effects on naturalistic social cognition (2021) (0)
- Task Switching Test (2015) (0)
- linically Unaffected First-Degree Relatives and irst-Episode and Chronic Schizophrenia (0)
- 117. Biomarker Assessment of Dose Dependent Target Engagement of mGluR-2,3 Partial Agonist for Schizophrenia Treatment (2019) (0)
- S.28.03 Glycine transport inhibitors for the treatment of psychiatric disorders (2011) (0)
- Theory of Mind (ToM) and counterfactuality deficits in schizophrenia: misperception or misinterpretation? – Corrigendum (2011) (0)
- Speaker: Lakshmi N. Yatham, Canada (2016) (0)
- COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS CROSS REFERENCE TO RELATED APPLICATIONS (2017) (0)
- Combined fMRI-EEG evidence for rhythmic and vigilant mode processing in the auditory cortex (2014) (0)
- M-Pathway Deficits in Schizophrenia: VEPS, Contrast Sensitivity and Functional Outcome (2002) (0)
- Hemispheric asymmetry of the superior temporal cortex in postmortem schizophrenic and control brains (2003) (0)
- S202. Event-Related Repetitive TMS to Right Posterior STS (but not OFA) in Healthy Volunteers (HV) Briefly Recapitulates Face Emotion Recognition (FER) Deficits of Schizophrenia (2018) (0)
- Substance Abuse: Phencyclidine Use Disorders (2015) (0)
- Deficits in generation of auditory event-related potentials, neuropsychological performance and psychopathology in chronic schizophrenia (1996) (0)
- Speaker: Tadafumi Kato, Japan (2016) (0)
- P.1.c.008 D-serine adjuvant treatment alleviates motor and behavioural symptoms in idiopathic Parkinson's disease (2009) (0)
- Madness in the garden or worm in the apple? (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Daniel C. Javitt?
Daniel C. Javitt is affiliated with the following schools:
